[Large deletion in mismatch repair genes uncovered by quantitative multiplex PCR-high performance liquid chromatography system].
Yaping Wang(Target (United States)), Xiaorong Liu(Hunan University of Traditional Chinese Medicine), Ming Zhu(AbbVie (United States)), Jun-ni Zhang, Menghong Sun, Xiaomei Zhang(Peking University), Jintian Li(South China Normal University)
PubMed
December 1, 2003
Cited by 0
Related Papers
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
|Journal of Clinical Oncology|2017|752
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
|The Lancet Oncology|2017|327
GWASdb: a database for human genetic variants identified by genome-wide association studies
|Nucleic Acids Research|2011|233
Efficacy and safety of ciprofol for the sedation/anesthesia in patients undergoing colonoscopy: Phase IIa and IIb multi-center clinical trials
|European Journal of Pharmaceutical Sciences|2021|203